Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,100 | 1 | 90.7% |
| Food and Beverage | $83.08 | 5 | 6.8% |
| Education | $29.99 | 1 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Avanir Pharmaceuticals, Inc. | $1,120 | 2 | $0 (2017) |
| Allergan, Inc. | $44.71 | 2 | $0 (2021) |
| Axsome Therapeutics, Inc. | $16.96 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $16.18 | 1 | $0 (2019) |
| ACADIA Pharmaceuticals Inc | $15.08 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $32.04 | 2 | Axsome Therapeutics, Inc. ($16.96) |
| 2021 | $29.99 | 1 | Allergan, Inc. ($29.99) |
| 2020 | $14.72 | 1 | Allergan, Inc. ($14.72) |
| 2019 | $16.18 | 1 | Janssen Pharmaceuticals, Inc ($16.18) |
| 2017 | $1,120 | 2 | Avanir Pharmaceuticals, Inc. ($1,120) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/22/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Psychology/Psychiatric | ||||||
| 01/12/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 01/13/2021 | Allergan, Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $29.99 | General |
| Category: NEUROSCIENCE | ||||||
| 02/03/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Neuroscience | ||||||
| 05/17/2017 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 05/12/2017 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: pseudobulbar affect (PBA) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 446 | 1,320 | $247,840 | $107,166 |
| 2022 | 9 | 479 | 1,392 | $194,635 | $117,539 |
| 2021 | 8 | 471 | 1,268 | $176,280 | $106,372 |
| 2020 | 10 | 513 | 1,291 | $184,290 | $97,796 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 129 | 811 | $141,800 | $59,635 | 42.1% |
| 90847 | Family psychotherapy with patient, 50 minutes | Office | 2023 | 49 | 173 | $32,000 | $13,854 | 43.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 56 | 56 | $14,600 | $8,705 | 59.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 52 | 52 | $14,300 | $7,448 | 52.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 37 | $5,550 | $3,857 | 69.5% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 32 | 56 | $11,920 | $3,438 | 28.8% |
| 99344 | Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 27 | 27 | $6,750 | $2,751 | 40.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 22 | 43 | $8,050 | $2,748 | 34.1% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 16 | 18 | $4,270 | $1,762 | 41.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 23 | 32 | $5,600 | $1,595 | 28.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 14 | 15 | $3,000 | $1,372 | 45.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 146 | 868 | $108,505 | $66,503 | 61.3% |
| 90847 | Family psychotherapy with patient, 50 minutes | Office | 2022 | 43 | 144 | $21,600 | $11,265 | 52.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 68 | 69 | $13,800 | $9,827 | 71.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 48 | 85 | $12,750 | $9,434 | 74.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 60 | 60 | $12,000 | $8,513 | 70.9% |
| 99348 | Established patient home visit, typically 25 minutes | Office | 2022 | 15 | 40 | $4,800 | $2,786 | 58.0% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 40 | 48 | $7,200 | $2,571 | 35.7% |
| 99344 | New patient home visit, typically 1 hour | Office | 2022 | 15 | 15 | $3,750 | $2,310 | 61.6% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 17 | 22 | $4,400 | $1,653 | 37.6% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 16 | 25 | $3,750 | $1,366 | 36.4% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 11 | 16 | $2,080 | $1,312 | 63.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 130 | 746 | $93,250 | $56,917 | 61.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 92 | 92 | $18,400 | $13,123 | 71.3% |
| 90847 | Family psychotherapy including patient, 50 minutes | Office | 2021 | 53 | 143 | $21,450 | $11,286 | 52.6% |
About Dr. Bruce Kaster, MD
Dr. Bruce Kaster, MD is a Geriatric Psychiatry healthcare provider based in Needham, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346281961.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Kaster, MD has received a total of $1,213 in payments from pharmaceutical and medical device companies, with $32.04 received in 2024. These payments were reported across 7 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1,100).
As a Medicare-enrolled provider, Kaster has provided services to 1,909 Medicare beneficiaries, totaling 5,271 services with total Medicare billing of $428,872. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Geriatric Psychiatry
- Location Needham, MA
- Active Since 06/08/2006
- Last Updated 04/16/2019
- Taxonomy Code 2084P0805X
- Entity Type Individual
- NPI Number 1346281961
Products in Payments
- NUEDEXTA (Drug) $1,120
- VRAYLAR (Drug) $44.71
- Auvelity (Drug) $16.96
- SPRAVATO (Drug) $16.18
- NUPLAZID (Drug) $15.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.